Cutting edge: Membrane lymphotoxin regulates CD8(+) T cell-mediated intestinal allograft rejection

Citation
Z. Guo et al., Cutting edge: Membrane lymphotoxin regulates CD8(+) T cell-mediated intestinal allograft rejection, J IMMUNOL, 167(9), 2001, pp. 4796-4800
Citations number
27
Categorie Soggetti
Immunology
Journal title
JOURNAL OF IMMUNOLOGY
ISSN journal
00221767 → ACNP
Volume
167
Issue
9
Year of publication
2001
Pages
4796 - 4800
Database
ISI
SICI code
0022-1767(20011101)167:9<4796:CEMLRC>2.0.ZU;2-S
Abstract
Blocking the CD28/B7 and/or CD154/CD40 costimulatory pathways promotes long -term allograft survival in many transplant models where CD4(+) T cells are necessary for rejection. When CD8(+) T cells are sufficient to mediate rej ection, these approaches fail, resulting in costimulation blockade-resistan t rejection. To address this problem we examined the role of lymphotoxin-re lated molecules in CD8(+) T cell-mediated rejection of murine intestinal al lografts. Targeting membrane lymphotoxin by means of a fusion protein, mAb, or genetic mutation inhibited rejection of intestinal allografts by CD8(+) T cells. This effect was associated with decreased monokine induced by IFN -gamma (Mig) and secondary lymphoid chemokine (SLC) gene expression within allografts and spleens respectively. Blocking membrane lymphotoxin did not inhibit rejection mediated by CD4(+) T cells. Combining disruption of membr ane lymphotoxin and treatment with CTLA4-Ig inhibited rejection in wild-typ e mice. These data demonstrate that membrane lymphotoxin is an important re gulatory molecule for CD8(+) T cells mediating rejection and suggest a stra tegy to avoid costimulation blockade-resistant rejection.